T 1329/11 (Use of BNP-type peptides/ROCHE) of 19.11.2015

European Case Law Identifier: ECLI:EP:BA:2015:T132911.20151119
Date of decision: 19 November 2015
Case number: T 1329/11
Application number: 05005356.0
IPC class: G01N 33/68
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 353 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: The use of BNP-type peptides and ANP-type peptides for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload
Applicant name: F. Hoffmann-La Roche AG
Roche Diagnostics GmbH
Opponent name: B.R.A.H.M.S GmbH
Board: 3.3.02
Headnote: -
Relevant legal provisions:
European Patent Convention Art 83
European Patent Convention Art 133
Rules of procedure of the Boards of Appeal Art 13
Keywords: Oral submission by accompanying person (refused)
Sufficiency of disclosure - (no)
Catchwords:

-

Cited decisions:
G 0004/95
Citing decisions:
T 1596/16

7 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPO Guidelines - F The European Patent Application

Offical Journal of the EPO

Case Law Book: II Conditions to be met by an Application

Case Law Book: III Amendments

Case Law of the Enlarged Board